Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-05

Clinical Trial Update: Dexmedetomidine Facilitate Analgesia [Phase 4]

View source ↗

Summary

Phase 4 trial update on dexmedetomidine for facilitating analgesia in lower limb fracture with nerve block.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: China International Neuroscience Institution | Conditions: Lower Limb Fracture, Nerve Block | Phase 4 | Status: COMPLETED